DK1249241T3 - Adsorbent til oral indgivelse - Google Patents

Adsorbent til oral indgivelse

Info

Publication number
DK1249241T3
DK1249241T3 DK02007918T DK02007918T DK1249241T3 DK 1249241 T3 DK1249241 T3 DK 1249241T3 DK 02007918 T DK02007918 T DK 02007918T DK 02007918 T DK02007918 T DK 02007918T DK 1249241 T3 DK1249241 T3 DK 1249241T3
Authority
DK
Denmark
Prior art keywords
units
lowered
gpt
adsorbent
meq
Prior art date
Application number
DK02007918T
Other languages
Danish (da)
English (en)
Inventor
Naohiro Sonobe
Michihito Ise
Susumu Morimoto
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Application granted granted Critical
Publication of DK1249241T3 publication Critical patent/DK1249241T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Steroid Compounds (AREA)
DK02007918T 2001-04-11 2002-04-09 Adsorbent til oral indgivelse DK1249241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001112264A JP3522708B2 (ja) 2001-04-11 2001-04-11 経口投与用吸着剤
CA2433368A CA2433368C (en) 2001-04-11 2003-06-25 Adsorbent for oral administration

Publications (1)

Publication Number Publication Date
DK1249241T3 true DK1249241T3 (da) 2007-10-22

Family

ID=34227260

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02007918T DK1249241T3 (da) 2001-04-11 2002-04-09 Adsorbent til oral indgivelse

Country Status (8)

Country Link
US (1) US20020176840A1 (enExample)
EP (1) EP1249241B9 (enExample)
JP (1) JP3522708B2 (enExample)
AT (1) ATE365558T1 (enExample)
CA (1) CA2433368C (enExample)
DE (2) DE60220849T4 (enExample)
DK (1) DK1249241T3 (enExample)
ES (1) ES2288176T3 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6830753B2 (en) 2001-04-11 2004-12-14 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
DE60213819T2 (de) * 2002-10-09 2007-08-09 Kureha Corp. Pharmazeutische Zubereitung enthaltend poröse sphärische kohlenstoffhaltige Teilchen und deren Verwendung zur Behandlung von Leber- und Nierenerkrankungen
EP1547605B1 (en) * 2002-11-01 2008-08-20 Kureha Corporation Adsorbents for oral administration
KR100680448B1 (ko) * 2002-11-01 2007-02-08 가부시키가이샤 쿠레하 경구투여용 흡착제, 신질환 치료 또는 예방제 및 간질환치료 또는 예방제
US7651974B2 (en) 2002-11-01 2010-01-26 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
JP3585043B2 (ja) 2003-01-22 2004-11-04 メルク・ホエイ株式会社 医薬用吸着剤及びその製法
KR20050119146A (ko) * 2003-04-03 2005-12-20 가부시끼가이샤 구레하 저대사 회전골증의 치료 또는 예방제
AU2003204621B8 (en) * 2003-06-11 2010-04-22 Kureha Corporation Adsorbent for oral administration
CN1615908B (zh) * 2003-10-22 2011-09-28 株式会社吴羽 口服给药用吸附剂、以及肾病治疗或预防剂、和肝病治疗或预防剂
TWI385120B (zh) * 2004-04-02 2013-02-11 Kureha Corp 球狀活性碳之製造方法
TWI370013B (en) 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
TWI370012B (en) * 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
TW200600099A (en) * 2004-05-18 2006-01-01 Kureha Chemical Ind Co Ltd Therapeutic or preventive agent for eye disease
CA2568801A1 (en) * 2004-06-02 2005-12-15 Kureha Corporation Agent for removing circulatory dysfunction factor
WO2005120458A1 (ja) * 2004-06-07 2005-12-22 Kureha Corporation 乾燥形態経口摂取用組成物及び用時調製形ゲル状経口摂取用組成物
JP4693030B2 (ja) * 2004-11-08 2011-06-01 オルガノ株式会社 活性炭の製造方法
EP1886689A4 (en) * 2005-05-16 2009-07-22 Kureha Corp INHIBITOR OF OXIDATIVE STRESS
JP2007045775A (ja) * 2005-08-11 2007-02-22 Japan Organo Co Ltd 含水活性炭及びその製造方法
US8247072B2 (en) 2006-02-14 2012-08-21 Eastman Chemical Company Resol beads, methods of making them and methods of using them
DE102008014109A1 (de) * 2008-03-13 2009-09-17 Bayer Animal Health Gmbh Suspensionsformulierung für Kohlenstoff-Adsorbentien
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
JP5424177B2 (ja) * 2009-01-29 2014-02-26 旭有機材工業株式会社 経口投与用吸着剤
JP5376592B2 (ja) * 2009-10-15 2013-12-25 産協企業有限股▲ふん▼公司 球形活性炭及びその製造方法
JP5765649B2 (ja) 2010-03-10 2015-08-19 株式会社ダステック 吸着炭及び吸着剤
JP5984352B2 (ja) 2010-10-12 2016-09-06 フタムラ化学株式会社 経口投与用医薬用吸着剤の製造方法
US20130344147A1 (en) 2011-03-04 2013-12-26 Ayumi Kainose Tablet-formed pharmaceutical composition for oral administration and method for producing same
GB201204696D0 (en) 2012-03-16 2012-05-02 Ucl Business Plc Therapy
CN105688832A (zh) * 2016-03-08 2016-06-22 东南大学 一种低成本改性烟草焦脱汞吸附剂的制备方法
JP7228498B2 (ja) 2018-10-24 2023-02-24 フタムラ化学株式会社 フェノール樹脂の製造方法
CN109135791A (zh) * 2018-10-24 2019-01-04 山西新华化工有限责任公司 工业化的沥青融并成球的制备方法
WO2020213559A1 (ja) 2019-04-16 2020-10-22 フタムラ化学株式会社 活性炭吸着剤の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS565313A (en) * 1979-06-26 1981-01-20 Kureha Chem Ind Co Ltd Detoxificating spherical active carbon and preparing the same
US4761284A (en) * 1977-12-27 1988-08-02 Kureha Kagaku Kogy Kabushiki Kaisha Antidote including activated carbon particles
JPS5489010A (en) * 1977-12-27 1979-07-14 Kureha Chem Ind Co Ltd Spherical activated charcoal antidote
JPS62223125A (ja) * 1979-06-26 1987-10-01 Kureha Chem Ind Co Ltd 経口解毒剤
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
CA2162086A1 (en) * 1994-11-15 1996-05-16 Michihito Ise Agent for reducing nephrotoxicity due to medicine
JPH08208491A (ja) * 1994-11-15 1996-08-13 Kureha Chem Ind Co Ltd 薬剤の腎毒性軽減剤

Also Published As

Publication number Publication date
ATE365558T1 (de) 2007-07-15
JP2002308785A (ja) 2002-10-23
EP1249241A1 (en) 2002-10-16
ES2288176T3 (es) 2008-01-01
EP1249241B1 (en) 2007-06-27
DE60220849D1 (de) 2007-08-09
DE60220849T2 (de) 2007-10-25
CA2433368C (en) 2011-07-05
EP1249241B9 (en) 2008-06-25
CA2433368A1 (en) 2004-12-25
DE60220849T4 (de) 2008-06-05
US20020176840A1 (en) 2002-11-28
JP3522708B2 (ja) 2004-04-26

Similar Documents

Publication Publication Date Title
DE60220849D1 (de) Adsorptionsmittel in oraler Darreichungsform
TW200517139A (en) Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
SE0101379D0 (sv) Komposition som hämmar utsöndring av magsyra
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
DK1227806T3 (da) Farmaceutisk præparat indeholdende tolterodin og dets anvendelse
JP2003500442A (ja) 化合物の抗菌剤としての新規な使用
EE200100161A (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
EP0311244B1 (en) Complex of magnesium oxide and titanium dioxide as a phosphate adsorbent
JP2002521468A5 (enExample)
CA2510949A1 (en) Polymorph of ritonavir
IL165027A (en) Stabilized pharmaceutical compositions based on purified polyoxyethylated castor oil and methods for manufacturing the same
IS3789A7 (is) Aðferð við framleiðslu lyfjaskammta í föstu formimeð tempraðri losun virks þáttar
WO2001080619A3 (en) Pharmaceutical composition containing citalopram
CA2268399A1 (en) Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
ATE335495T1 (de) Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen
Rosowsky et al. Methotrexate analogues—XVII: Antitumor activity of 4-amino-4-deoxy-N10-methylpteroyl-d, l-homocysteic acid and its dual inhibition of dihydrofolate reductase and folyl polyglutamate synthetase
JP2006111604A5 (enExample)
RU2003135201A (ru) Применение антагониста опиоидов налтрексона для предупреждения и контроля побочных воздействий, вызванных опиоидами
EP1652532A1 (en) Medicinal composition
TW200500084A (en) Adsorbent for oral administration and pharmaceutical composition, and method of manufacturing absorbent for oral administration
EP0916663A1 (en) 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3,13(16), 14-clerodatrien-2-one (Esculentin A) and 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3, 12, 14-clerodatrien-2Beta-isovaleryloxy-6Beta, 7Alpha-diol (Esculentin B), a process for their preparation, and their use in the manufacture of medicaments
JP2004501060A (ja) オピオイド受容体に対する親和性を有する３級アミノ化合物
JP3753285B2 (ja) サイトキサゾン、その製造方法、免疫調節剤、及び抗癌剤
NO20016255L (no) Kromeno[4,3,2-de]isoquinoline som potente dopamineresepter ligander
US20030044461A1 (en) Antitussive/expectorant compositions